Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Public ClinicalTrials.gov record NCT07118176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PET Imaging Study of 68Ga-FAPI-46 Biodistribution in Cancer Patients
Study identification
- NCT ID
- NCT07118176
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Jonsson Comprehensive Cancer Center
- Other
- Enrollment
- 30 participants
Conditions and interventions
Conditions
- Anal Carcinoma
- Bladder Carcinoma
- Breast Carcinoma
- Cervical Carcinoma
- Cholangiocarcinoma
- Colorectal Carcinoma
- Esophageal Carcinoma
- Gastric Carcinoma
- Head and Neck Carcinoma
- Hematopoietic and Lymphatic System Neoplasm
- Hepatocellular Carcinoma
- Lung Carcinoma
- Malignant Adrenal Gland Neoplasm
- Malignant Brain Neoplasm
- Malignant Neoplasm of Unknown Primary
- Malignant Solid Neoplasm
- Malignant Testicular Neoplasm
- Malignant Uterine Neoplasm
- Neuroendocrine Neoplasm
- Ovarian Carcinoma
- Pancreatic Carcinoma
- Penile Carcinoma
- Pleural Carcinomatosis
- Primary Peritoneal Carcinoma
- Prostate Carcinoma
- Salivary Gland Carcinoma
- Sarcoma
- Skin Carcinoma
- Solitary Fibrous Tumor
- Thymus Carcinoma
- Thyroid Gland Carcinoma
- Thyroid Gland Medullary Carcinoma
- Urothelial Carcinoma
- Vaginal Carcinoma
Interventions
- Computed Tomography Procedure
- Fludeoxyglucose F-18 Other
- Gallium Ga 68 FAPi-46 Radiation
- Positron Emission Tomography Procedure
Procedure · Other · Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2025
- Primary completion
- Sep 5, 2026
- Completion
- Sep 6, 2027
- Last update posted
- Aug 11, 2025
2025 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA / Jonsson Comprehensive Cancer Center | Los Angeles | California | 90095 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07118176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2025 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07118176 live on ClinicalTrials.gov.